RSC Advances,
Journal Year:
2024,
Volume and Issue:
14(29), P. 21203 - 21212
Published: Jan. 1, 2024
The
coronavirus
disease
2019
(COVID-19)
has
spread
worldwide
with
severe
health,
social,
and
economic
repercussions.
Although
vaccines
have
significantly
reduced
the
severity
of
symptoms
deaths,
alternative
medications
derived
from
natural
products
(NPs)
are
vital
to
further
decrease
fatalities,
especially
in
regions
low
vaccine
uptake.
When
paired
latest
computational
developments,
NPs,
which
been
used
cure
illnesses
infections
for
thousands
years,
constitute
a
renewed
resource
drug
discovery.
In
present
report,
combination
vitro
methods
reveals
repositioning
NPs
identifies
salvinorin
A
deacetylgedunin
(DCG)
as
having
potential
anti-SARS-CoV-2
activities.
Salvinorin
was
found
both
silico
inhibit
SARS-CoV-2
spike/host
ACE2
protein
interactions,
consistent
blocking
viral
cell
entry,
well
live
virus
replication.
Plant
extracts
Azadirachta
indica
Cedrela
odorata,
contain
high
levels
DCG,
inhibited
replication
by
targeting
main
protease
(Mpro)
and/or
entry
interaction
between
spike
RBD-ACE2
at
concentrations
lower
than
A.
Our
findings
suggest
that
represent
promising
chemical
starting
points
where
optimization
may
result
effective
product-derived
potent
inhibitors
supplement
efforts.
Biomedicines,
Journal Year:
2021,
Volume and Issue:
9(6), P. 689 - 689
Published: June 18, 2021
As
a
public
health
emergency
of
international
concern,
the
highly
contagious
coronavirus
disease
2019
(COVID-19)
pandemic
has
been
identified
as
severe
threat
to
lives
billions
individuals.
Lung
cancer,
malignant
tumor
with
highest
mortality
rate,
brought
significant
challenges
both
human
and
economic
development.
Natural
products
may
play
pivotal
role
in
treating
lung
diseases.
We
reviewed
published
studies
relating
natural
products,
used
alone
or
combination
US
Food
Drug
Administration-approved
drugs,
active
against
acute
respiratory
syndrome
2
(SARS-CoV-2)
cancer
from
1
January
2020
31
May
2021.
A
wide
range
can
be
considered
promising
anti-COVID-19
anti-lung
agents
have
gained
widespread
attention,
including
monotherapy
for
treatment
SARS-CoV-2
(ginkgolic
acid,
shiraiachrome
A,
resveratrol,
baicalein)
(daurisoline,
graveospene
deguelin,
erianin)
FDA-approved
anti-SARS-CoV-2
(cepharanthine
plus
nelfinavir,
linoleic
acid
remdesivir)
(curcumin
cisplatin,
celastrol
gefitinib).
demonstrated
potential
value
assistance
nanotechnology,
drug
therapies,
codrug
strategy,
this
“natural
remedy”
could
serve
starting
point
further
development
these
Chemical Papers,
Journal Year:
2024,
Volume and Issue:
78(6), P. 3431 - 3441
Published: March 14, 2024
Abstract
Chemical
prototypes
with
broad-spectrum
antiviral
activity
are
important
toward
developing
new
therapies
that
can
act
on
both
existing
and
emerging
viruses.
Binding
of
the
SARS-CoV-2
spike
protein
to
host
angiotensin-converting
enzyme
2
(ACE2)
receptor
is
required
for
cellular
entry
SARS-CoV-2.
Toward
identifying
chemical
leads
disrupt
this
interaction,
including
in
presence
adaptive
mutations
found
variants
like
omicron
circumvent
vaccine,
immune,
therapeutic
antibody
responses,
we
synthesized
5-chloro-3-(2-(2,4-dinitrophenyl)hydrazono)indolin-2-one
(H
L)
from
condensation
reaction
5-chloroisatin
2,4-dinitrophenylhydrazine
good
yield.
H
L
was
characterised
by
elemental
spectral
(IR,
electronic,
Mass)
analyses.
The
NMR
spectrum
indicated
a
keto–enol
tautomerism,
keto
form
being
more
abundant
solution.
selectively
interfere
binding
receptor-binding
domain
(RBD)
50%
inhibitory
concentration
(IC
50
)
0.26
μM,
compared
an
unrelated
PD-1/PD-L1
ligand–receptor-binding
pair
IC
2.06
μM
vitro
(Selectivity
index
=
7.9).
Molecular
docking
studies
revealed
ligand
preferentially
binds
within
ACE2
site
region
distinct
where
occur.
Consistent
these
models,
able
interactions
RBDs
beta,
delta,
lambda,
similar
activities.
These
indicate
L-derived
compounds
potential
inhibitors
multiple
variants,
those
capable
circumventing
vaccine
immune
responses.
Medicinal Chemistry Research,
Journal Year:
2024,
Volume and Issue:
33(4), P. 620 - 634
Published: March 5, 2024
Abstract
Isatin
(indol-2,3-dione),
a
secondary
metabolite
of
tryptophan,
has
been
used
as
the
core
structure
to
design
several
compounds
that
have
tested
and
identified
potent
inhibitors
apoptosis,
potential
antitumor
agents,
anticonvulsants,
antiviral
agents.
In
this
work,
analogs
isatin
hybrids
synthesized
characterized,
their
activities
were
established
both
Aurora
A
kinase
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
spike/host
angiotensin-converting
enzyme
II
(ACE2)
interactions.
Amongst
hybrids,
6a
,
6f
6g
6m
exhibited
inhibitory
(with
IC
50
values
<
5
$$\mu$$
μ
M),
with
GScore
−7.9,
−7.6,
−8.2
−7.7
kcal/mol,
respectively.
Compounds
6i
showed
in
blocking
SARS-CoV-2
spike/ACE2
binding
range
30
−6.4
−6.6
capable
inhibiting
kinase.
Pharmacophore
profiling
indicated
compound
tightly
fits
pharmacophores,
while
6d
6l
pharmacophore.
This
work
is
proof
concept
some
existing
cancer
drugs
may
possess
properties.
Molecular
modeling
active
for
each
protein
adopted
different
modes,
hence
interacting
set
amino
acid
residues
site.
The
weaker
against
could
be
explained
by
small
sizes
ligands
fail
address
important
interactions
ACE2
receptor
The Microbe,
Journal Year:
2024,
Volume and Issue:
3, P. 100059 - 100059
Published: March 23, 2024
In
silico
binding
studies
were
conducted
on
the
known
plant-derived
polyphenolic
tetrameric
stilbenoids,
(–)-hopeaphenol
(1),
vaticanol
B
(2)
and
vatalbinoside
A
(3)
their
monomeric
derivative
resveratrol
(8),
identified
from
several
plant
species.
The
natural
products
1–3
had
been
previously
evaluated
against
SARS-CoV-2
protein
targets
responsible
for
viral
transmission
infection.
two
isomeric
compounds
displayed
a
high
affinity
blocking
of
spike
with
human
angiotensin-converting
enzyme
2
(ACE2).
Molecular
docking
molecular
dynamics
simulations
have
used
to
attempt
explain
spike/ACE2
complex.
hydrophobic
properties
respective
target
sites
computed
compared
physicochemical
each
compound
toward
site.
ADMET/DMPK
profiles
also
demonstrate
potential
fragments
as
lead
antiviral
discovery.
These
results
reported
here
support
experimental
data
obtained
date
clearly
identify
stilbenoid
structure
class
one
worthy
future
during
chemical
biology
and/or
drug
discovery
efforts.
Molecules,
Journal Year:
2024,
Volume and Issue:
29(14), P. 3427 - 3427
Published: July 22, 2024
Phenolic
compounds
are
the
main
special
metabolites
of
Cyperaceae
species
from
phytochemical,
pharmacological,
and
chemotaxonomical
points
view.
The
present
study
focused
on
isolation,
structure
determination,
pharmacological
investigation
constituents
Carex
praecox.
Twenty-six
compounds,
including
lignans,
stilbenes,
flavonoids,
megastigmanes,
chromenes,
phenylpropanoids,
were
identified
methanol
extract
plant.
Five
these
namely,
carexines
A–E,
previously
undescribed
natural
products.
All
isolated
for
first
time
C.
ACE-inhibitory
activity
seven
stilbenoid
was
tested,
(–)-hopeaphenol
proved
to
be
most
active
(IC50
7.7
±
0.9
μM).
enzyme–kinetic
studies
revealed
a
mixed-type
inhibition;
therefore,
domain-specific
also
conducted.
in
silico
docking
ACE
affirmed
some
favorable
interactions.
In
addition,
antiproliferative
antibacterial
effects
evaluated.
Nutrients,
Journal Year:
2022,
Volume and Issue:
14(7), P. 1390 - 1390
Published: March 26, 2022
Patients
affected
by
coronavirus
disease
2019
(COVID-19)
demonstrate
a
range
of
hemostasis
dysfunctions,
such
as
coagulation
dysfunction
and
changes
in
blood
platelet
function,
this
being
major
cause
death.
These
complications
may
also
be
associated
with
oxidative
stress.
Recently,
various
papers,
including
some
reviews,
have
suggested
that
the
use
dietary
bioactive
compounds,
phenolic
play
significant
role
treatment
COVID-19.
However,
while
curcumin,
resveratrol,
myricetin
scutellarian,
been
found
to
antiviral
effects
against
COVID-19,
recommendations
regarding
compounds
prevent
or
reduce
risk
CVDs
during
COVID-19
infection
remain
tentative.
The
present
mini-review
examines
antioxidant,
anti-platelet
anticoagulant
activities
selected
possible
implications
for
their
treating
This
review
whether
these
can
promising
agents
modulation
While
properties
well
documented
vitro
vivo
studies,
particularly
positive
prophylaxis
CVDs,
less
is
known
prophylactic
potential
no
credible
evidence
exists
efficiency
humans
animals.
In
cases,
studies
are
available.
Therefore,
it
cannot
unequivocally
stated
offers
benefits
patients
Nutrients,
Journal Year:
2023,
Volume and Issue:
15(18), P. 3885 - 3885
Published: Sept. 6, 2023
The
COVID-19
pandemic
has
stimulated
collaborative
drug
discovery
efforts
in
academia
and
the
industry
with
aim
of
developing
therapies
vaccines
that
target
SARS-CoV-2.
Several
novel
have
been
approved
deployed
last
three
years.
However,
their
clinical
application
revealed
limitations
due
to
rapid
emergence
viral
variants.
Therefore,
development
next-generation
SARS-CoV-2
therapeutic
agents
a
high
potency
safety
profile
remains
priority
for
global
health.
Increasing
awareness
“back
nature”
approach
improving
human
health
prompted
renewed
interest
natural
products,
especially
dietary
polyphenols,
as
an
additional
strategy
treat
patients,
owing
its
good
profile,
exceptional
nutritional
value,
health-promoting
benefits
(including
potential
antiviral
properties),
affordability,
availability.
Herein,
we
describe
biological
properties
pleiotropic
molecular
mechanisms
polyphenols
curcumin,
resveratrol,
gossypol
inhibitors
against
variants
observed
vitro
vivo
studies.
Based
on
advantages
disadvantages
obtain
maximal
benefits,
several
strategies
such
nanotechnology
(e.g.,
curcumin-incorporated
nanofibrous
membranes
antibacterial-antiviral
ability),
lead
optimization
methylated
analog
curcumin),
combination
specific
plant
extracts
micronutrients),
broad-spectrum
activities
broadly
inhibits
coronaviruses)
also
emphasized
positive
factors
facilitation
anti-SARS-CoV-2
support
effective
long-term
management
control.
Chemistry & Biodiversity,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 24, 2024
Abstract
Due
to
the
significance
of
variable
chemical
groups
across
a
wide
spectrum
modern
medicine,
it
is
imperative
determine
what
most
widely
used
group
in
medical
applications
with
fewest
side
effects.
Ten
compounds
from
ten
that
are
commonly
known
for
their
uses
were
compared
terms
therapeutic
potential
and
The
comparison
among
selected
indicated
superiority
flavonoids
over
other
multitude
utilizations
lower
Kaempferol
quercetin
showed
higher
utilization
Whereas
alkaloid
lowest
levels
use
highest
Based
on
conducted,
concluded
give
priority
flavonoid
being
because
they
exhibit
Within
flavonoids,
kaempferol
two
highly
recommended
be
widest
range
applications.
Serious
caution
should
considered
before
applying
alkaloids
any
service.
Understanding
characteristics
these
can
aid
developing
safer
more
effective
treatments
medicinal
plants.